Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Neoplasms 1Nalbuphine Allergy 1Mouth Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Emergence Delirium 1Chronic Pain 1Breast Neoplasms 1

Interventions

Bupivacaine 31Ropivacaine 19Dexmedetomidine 19Saline Solution 18Morphine 12Ketamine 12Sodium Chloride 10Pregabalin 9Lidocaine 9Acetaminophen 9Control Groups 7Injections, Epidural 5Gabapentin 4Epinephrine 4Dexamethasone 4Anesthetics, Local 4Anesthesia, General 4Analgesia, Patient-Controlled 4parecoxib 3oxycodone-acetaminophen 3Tea 3Midazolam 3Ketorolac 3Fentanyl 3Esketamine 3Dental Occlusion 3Vitamins 2Tramadol 2Surgical Procedures, Operative 2Sufentanil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pain, Postoperative × Nalbuphine × Clear all
NCT07197684 2026-02-19

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Aga Khan University

Phase NA Not yet recruiting
120 enrolled
Breast

Breast Neoplasms, Pain, Postoperative, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡